Outcome of board meeting of Natco Pharma

4 Sep 2022 , 01:33 AM

The Board of Natco Pharma at its meeting held on 02 September 2022 has approved the following To sell the investment of 15Percentage of shareholding in Joint Limited Liability Company JLLC Nativita a Company registered under the Companies Law of the Republic of Belarus for an amount of 345000 Euros to Ms Pharmasyntez-Nord Joint Stock Company a legal entity under the laws of the Russian Federation subject to the approval of the Statutory and Regulatory Authorities To assign the leasehold land wherein the Companys Pharma Division is situated ie Plot No 19 and Plot No 18-A situated at Pharma City SIIDCUL Selaqui Tehsil – Vikasnagar Dehradun Uttarakhand India and sell the buildings plant machinery and fixtures constructed andor installed in Plot No 19 to Ms Odon Lifesciences for an amount of Rs1573 crore which is subject to the approval of State Infrastructure and Industrial Development Corporation of Uttarakhand SIIDCUL other Statutory and Regulatory Authorities